ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Hyperbranched Biorefinery Molecule-Regulated Switchable Adhesion and Noninvasive Healing.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Switchable adhesives hold great potential in fields like flexible electronics, soft robotics, and tissue repair, etc. However, creating bio-based switchable adhesives for biomedical use remains challenging due to the difficulty in balancing high strength and a broad adhesion span. Here, we report a dynamic chemical modification strategy based on biorefinery-derived hyperbranched nanoconfinement to fabricate a switchable adhesive for biomedical applications. Microbial fermentation produces hyperbranched biorefinery molecules with nanostructures that address common biomass-related issues like long production cycles, unstable batches, and by-product generation, while also providing abundant binding sites for high-density dynamic bonds. This hyperbranched nanoconfinement enables substantial energy dissipation, facilitating efficient stress redistribution and interfacial reconfiguration at fracture sites, thereby achieving simultaneously excellent adhesive strength and switchable adhesion. The resulting switchable wound bioadhesive exhibits a wide switching span (296 to 17 N/m) and high stability, enabling non-invasive repair with a 94.80% wound closure rate after 10 days, significantly higher than the control (76.07%). This work explores the application of biorefinery molecules in the field of bio-based adhesives and develops a promising candidate for innovating adhesion solutions in the biomedical field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.